Feedback / Questions
bempikibart (ADX-914) - Q32 Bio
https://www.prnewswire.com/news-releases/q32-bio-presents-results-from-part-b-of-the-signal-aa-clinical-trial-of-bempikibart-in-alopecia-areata-in-a-late-breaker-at-the-european-academy-of-dermatology-and-venereology-congress-2026-302893654.html
Sep 30, 2026
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next